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Background
Bioprocesses like the cell-based production of biologi-
cals, i.e. mainly recombinant proteins and monoclonal
antibodies, require optimal culture conditions to obtain
a high yield of quality products. The performance of a
bioreactor highly depends on the cell characteristics as
well as on the composition of the cell culture medium
and the process conditions. As the metabolic activity
of the cells is very high during fermentation, the exter-
nal and internal metabolite compositions vary tremen-
dously throughout the process. The quantification of a
wide range of metabolic substrates and products is a
prerequisite to understand and optimize the underlying
cell-based activities. Furthermore, metabolite quantifi-
cation reveals the composition of biologically derived
cell culture supplements, thus serving as a tool to
monitor supplement quality or providing the base for
the formulation of a chemically defined medium
supplement.
Materials and methods
Targeted metabolomics was carried out using a mass
spectrometry-based platform. Analyses were performed
with commercially available KIT plates that allow the
simultaneous quantification of 180 metabolites [1]. The
fully automated assay is based on PITC (phenylisothio-
cyanate)-derivatization in the presence of internal stan-
dards followed by FIA-MS/MS (for acylcarnitines, lipids,
hexoses) as well as LC-MS/MS (amino acids and bio-
genic amines) using a AB SCIEX 4000 QTrap mass
spectrometer in the multiple reaction monitoring detec-
tion mode with electrospray ionization. On the same
instrument, a validated HPLC-MS/MS quantification
method is used for the analysis of energy metabolism
intermediates. The concentrations of individual fatty
acids are determined as their corresponding methyl
ester derivatives (FAME’s) using GC-MS on an Agilent
7890 GC/5795 MSD instrument after derivatization.
Vitamins were determined using LC-ESI-MS/MS techni-
que after their pre-separation into two fractions (water-
and fat-soluble vitamins).
Results
The metabolomics approach to bioprocess monitoring
made it possible to determine the concentration of a
multitude of analytes from several metabolite classes in
a sample- and time-efficient way by using small sample
volumes and a multi-assay strategy. The analyte portfo-
lio went beyond routinely determined culture media
components, as it covered proteinogenic and non-pro-
teinogenic amino acids, e.g. ornithine and citrulline, and
intermediates of the energy metabolism, e.g. lactate,
hexoses, succinate, as well as acylcarnitines, biogenic
amines, glycerophospholipids, sphingomyelins, fatty
acids, and vitamins (Figure 1).
Conclusions
Targeted metabolomics comprises a rapid and compre-
hensive method to determine the composition of cell
culture supplements of biological origin.
The method is also well suited to rapidly characterize
fermentational processes metabolically by monitoring
changes in medium composition and cellular metabo-
lite pools. The received quantitative data can be
directly related to growth, vitality, and productivity of
the cell.
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any medium, provided the original work is properly cited.Figure 1 Comparison of the metabolite spectrum of commercially available cell culture media supplements derived from biological sources.
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